Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting

Amsterdam, The Netherlands, November 7, 2018 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces two data presentations at the 60th American Society of Hematology (ASH) Annual Meeting. The event will be held December 1-4, 2018, at the San Diego Convention Center in San Diego, CA.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH